MARKET

CRBU

CRBU

Caribou Biosciences, Inc.
NASDAQ
1.570
0.000
0.00%
After Hours: 1.600 +0.03 +1.91% 19:30 09/04 EDT
OPEN
1.570
PREV CLOSE
1.570
HIGH
1.600
LOW
1.550
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
3.535
52 WEEK LOW
1.380
MARKET CAP
168.32M
P/E (TTM)
-1.4568
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CRBU last week (0824-0828)?
Weekly Report · 6d ago
Here's Why You Should Retain IQVIA Stock in Your Portfolio Now
NASDAQ · 08/26 15:17
Weekly Report: what happened at CRBU last week (0817-0821)?
Weekly Report · 08/24 09:58
RBC Capital Keeps Their Buy Rating on Caribou Biosciences (CRBU)
TipRanks · 08/17 10:29
Weekly Report: what happened at CRBU last week (0810-0814)?
Weekly Report · 08/17 09:58
Caribou Biosciences reports Q2 EPS (24c), consensus (31c)
TipRanks · 08/16 14:03
Caribou Biosciences price target lowered to $5 from $6 at BofA
TipRanks · 08/16 13:45
Caribou Biosciences Price Target Cut to $5.00/Share From $6.00 by B of A Securities
Dow Jones · 08/14 18:35
More
About CRBU
Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. The Company is dedicated to developing transformative therapies for patients with devastating diseases. The Company's chRDNA genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against disease. Caribou is focused on vispacabtagene regedleucel (vispa-cel) and CB-011 as off-the-shelf CAR-T cell therapies that have the potential to provide broad access and rapid treatment for patients with hematologic malignancies. Vispa-cel is an allogeneic anti-CD19 CAR-T cell therapy that has been evaluated in patients with relapsed or refractory B cell non-Hodgkin lymphoma. CB-011 is an allogeneic anti-BCMA CAR-T cell therapy that is being evaluated in patients with relapsed or refractory multiple myeloma.

Webull offers Caribou Biosciences Inc stock information, including NASDAQ: CRBU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRBU stock methods without spending real money on the virtual paper trading platform.